Danielle Cooke
Concepts (534)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intracranial Arteriovenous Malformations | 27 | 2023 | 53 | 5.810 |
Why?
| | Embolization, Therapeutic | 30 | 2026 | 243 | 5.490 |
Why?
| | Intracranial Aneurysm | 23 | 2026 | 105 | 5.470 |
Why?
| | Endovascular Procedures | 25 | 2026 | 400 | 4.130 |
Why?
| | Central Nervous System Vascular Malformations | 14 | 2026 | 27 | 2.600 |
Why?
| | Cerebral Angiography | 25 | 2024 | 119 | 2.180 |
Why?
| | Subarachnoid Hemorrhage | 10 | 2022 | 71 | 2.170 |
Why?
| | Stents | 12 | 2026 | 570 | 2.080 |
Why?
| | Endothelial Cells | 9 | 2024 | 866 | 2.060 |
Why?
| | Biopsy | 8 | 2024 | 1081 | 1.940 |
Why?
| | Stroke | 19 | 2023 | 1272 | 1.840 |
Why?
| | Angiography, Digital Subtraction | 17 | 2025 | 48 | 1.770 |
Why?
| | Aneurysm, Ruptured | 7 | 2022 | 38 | 1.680 |
Why?
| | Arteriovenous Fistula | 8 | 2025 | 38 | 1.610 |
Why?
| | Robotics | 3 | 2024 | 90 | 1.370 |
Why?
| | Tomography, X-Ray Computed | 19 | 2025 | 2772 | 1.350 |
Why?
| | Brain Ischemia | 10 | 2022 | 360 | 1.090 |
Why?
| | Basilar Artery | 2 | 2018 | 7 | 1.080 |
Why?
| | Intracranial Hemorrhages | 7 | 2022 | 106 | 1.070 |
Why?
| | Retinoblastoma | 5 | 2023 | 42 | 1.040 |
Why?
| | Retinal Neoplasms | 4 | 2018 | 37 | 0.990 |
Why?
| | Fluoroscopy | 8 | 2018 | 181 | 0.990 |
Why?
| | Vasospasm, Intracranial | 6 | 2017 | 19 | 0.990 |
Why?
| | Automobile Driver Examination | 1 | 2026 | 9 | 0.960 |
Why?
| | Feasibility Studies | 6 | 2022 | 1119 | 0.900 |
Why?
| | Humans | 157 | 2026 | 145491 | 0.900 |
Why?
| | Magnetic Resonance Imaging | 23 | 2025 | 3897 | 0.890 |
Why?
| | Self-Management | 2 | 2025 | 201 | 0.870 |
Why?
| | Neurosurgery | 2 | 2022 | 41 | 0.850 |
Why?
| | Iliac Artery | 2 | 2014 | 60 | 0.810 |
Why?
| | Automobile Driving | 1 | 2026 | 157 | 0.810 |
Why?
| | Risk Reduction Behavior | 1 | 2025 | 217 | 0.800 |
Why?
| | Phantoms, Imaging | 6 | 2018 | 159 | 0.790 |
Why?
| | Magnetic Resonance Imaging, Interventional | 6 | 2016 | 32 | 0.780 |
Why?
| | Vascular Malformations | 5 | 2022 | 51 | 0.760 |
Why?
| | Radiography, Interventional | 5 | 2023 | 135 | 0.760 |
Why?
| | Middle Aged | 67 | 2026 | 36176 | 0.760 |
Why?
| | Endothelium, Vascular | 3 | 2019 | 951 | 0.750 |
Why?
| | Educational Measurement | 1 | 2026 | 325 | 0.750 |
Why?
| | Retrospective Studies | 61 | 2026 | 17269 | 0.750 |
Why?
| | Robotic Surgical Procedures | 2 | 2025 | 183 | 0.750 |
Why?
| | Male | 90 | 2026 | 72817 | 0.740 |
Why?
| | Stroke Rehabilitation | 1 | 2023 | 43 | 0.740 |
Why?
| | Thrombectomy | 8 | 2022 | 79 | 0.740 |
Why?
| | Cerebral Hemorrhage | 7 | 2022 | 125 | 0.730 |
Why?
| | Aneurysm | 3 | 2021 | 37 | 0.730 |
Why?
| | Brain | 17 | 2025 | 2944 | 0.730 |
Why?
| | Radiosurgery | 8 | 2022 | 399 | 0.720 |
Why?
| | Software | 4 | 2020 | 698 | 0.710 |
Why?
| | Treatment Outcome | 35 | 2026 | 11831 | 0.660 |
Why?
| | Cerebral Arteries | 4 | 2017 | 59 | 0.660 |
Why?
| | Carotid Stenosis | 1 | 2022 | 107 | 0.650 |
Why?
| | Magnetic Resonance Angiography | 6 | 2020 | 251 | 0.650 |
Why?
| | Female | 88 | 2026 | 78763 | 0.630 |
Why?
| | Balloon Occlusion | 1 | 2020 | 39 | 0.630 |
Why?
| | Neuroimaging | 6 | 2025 | 293 | 0.630 |
Why?
| | Aged | 51 | 2026 | 26125 | 0.620 |
Why?
| | Central Nervous System Diseases | 1 | 2021 | 74 | 0.620 |
Why?
| | Veins | 3 | 2022 | 70 | 0.620 |
Why?
| | Carotid Artery, Common | 1 | 2020 | 31 | 0.610 |
Why?
| | Vascular Access Devices | 3 | 2018 | 32 | 0.610 |
Why?
| | Cerebral Veins | 3 | 2021 | 16 | 0.610 |
Why?
| | Melphalan | 3 | 2018 | 43 | 0.580 |
Why?
| | Needles | 2 | 2018 | 62 | 0.570 |
Why?
| | Catheterization, Peripheral | 3 | 2016 | 121 | 0.570 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2018 | 20 | 0.560 |
Why?
| | Transcranial Magnetic Stimulation | 5 | 2020 | 65 | 0.560 |
Why?
| | Graft Occlusion, Vascular | 1 | 2018 | 41 | 0.550 |
Why?
| | Wounds, Stab | 1 | 2018 | 12 | 0.550 |
Why?
| | Jugular Veins | 1 | 2018 | 42 | 0.540 |
Why?
| | Neck Injuries | 1 | 2018 | 21 | 0.530 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2022 | 505 | 0.530 |
Why?
| | Aorta, Thoracic | 1 | 2020 | 286 | 0.510 |
Why?
| | Nerve Net | 5 | 2020 | 284 | 0.510 |
Why?
| | Lymphatic Abnormalities | 3 | 2022 | 20 | 0.500 |
Why?
| | Obsessive-Compulsive Disorder | 3 | 2023 | 59 | 0.500 |
Why?
| | Adult | 52 | 2026 | 40707 | 0.490 |
Why?
| | Angioplasty | 3 | 2022 | 50 | 0.460 |
Why?
| | Vertebrobasilar Insufficiency | 1 | 2015 | 10 | 0.450 |
Why?
| | Orbital Diseases | 2 | 2018 | 37 | 0.440 |
Why?
| | Disease Management | 3 | 2017 | 654 | 0.440 |
Why?
| | Tissue and Organ Harvesting | 1 | 2015 | 78 | 0.420 |
Why?
| | Renal Dialysis | 1 | 2018 | 465 | 0.410 |
Why?
| | Ventriculostomy | 3 | 2026 | 24 | 0.410 |
Why?
| | Magnetic Fields | 2 | 2014 | 24 | 0.410 |
Why?
| | Neural Pathways | 4 | 2020 | 312 | 0.410 |
Why?
| | Spinal Cord | 4 | 2025 | 384 | 0.400 |
Why?
| | Image Interpretation, Computer-Assisted | 2 | 2020 | 289 | 0.400 |
Why?
| | Cell Separation | 1 | 2013 | 304 | 0.370 |
Why?
| | Pitch Perception | 2 | 2025 | 14 | 0.370 |
Why?
| | Cerebral Infarction | 3 | 2025 | 47 | 0.370 |
Why?
| | Mammary Arteries | 1 | 2012 | 9 | 0.370 |
Why?
| | Infusions, Intra-Arterial | 6 | 2018 | 61 | 0.360 |
Why?
| | Infarction, Middle Cerebral Artery | 2 | 2013 | 42 | 0.360 |
Why?
| | Blood Vessel Prosthesis | 3 | 2019 | 140 | 0.360 |
Why?
| | Cerebrovascular Disorders | 2 | 2024 | 106 | 0.360 |
Why?
| | Vertebral Artery Dissection | 1 | 2012 | 30 | 0.360 |
Why?
| | Clinical Protocols | 3 | 2018 | 282 | 0.360 |
Why?
| | Deep Brain Stimulation | 1 | 2015 | 216 | 0.350 |
Why?
| | Catheters | 4 | 2017 | 76 | 0.350 |
Why?
| | Brain Neoplasms | 2 | 2025 | 1329 | 0.340 |
Why?
| | Sclerotherapy | 4 | 2022 | 19 | 0.340 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 3 | 2021 | 254 | 0.340 |
Why?
| | Diffusion Magnetic Resonance Imaging | 2 | 2026 | 155 | 0.340 |
Why?
| | Radial Artery | 2 | 2021 | 75 | 0.330 |
Why?
| | Temporal Arteries | 1 | 2011 | 45 | 0.330 |
Why?
| | Cochlear Implants | 2 | 2025 | 96 | 0.330 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2025 | 2582 | 0.330 |
Why?
| | Atherosclerosis | 1 | 2015 | 410 | 0.330 |
Why?
| | Carotid Artery, Internal | 4 | 2019 | 45 | 0.320 |
Why?
| | Neuronavigation | 1 | 2010 | 8 | 0.320 |
Why?
| | Transcriptome | 3 | 2022 | 1038 | 0.310 |
Why?
| | Surgical Instruments | 1 | 2010 | 51 | 0.310 |
Why?
| | Ultrasonography, Doppler, Transcranial | 4 | 2017 | 48 | 0.300 |
Why?
| | Arteriovenous Malformations | 2 | 2020 | 32 | 0.300 |
Why?
| | Aged, 80 and over | 14 | 2026 | 8326 | 0.300 |
Why?
| | MAP Kinase Signaling System | 2 | 2021 | 306 | 0.290 |
Why?
| | Carotid-Cavernous Sinus Fistula | 2 | 2019 | 9 | 0.290 |
Why?
| | Cardiac Catheterization | 1 | 2013 | 570 | 0.290 |
Why?
| | Adolescent | 25 | 2026 | 22485 | 0.280 |
Why?
| | Brain Mapping | 5 | 2020 | 536 | 0.280 |
Why?
| | Connectome | 5 | 2020 | 93 | 0.280 |
Why?
| | Magnetics | 4 | 2016 | 47 | 0.270 |
Why?
| | Vasodilator Agents | 1 | 2010 | 330 | 0.270 |
Why?
| | Ophthalmic Artery | 2 | 2018 | 7 | 0.270 |
Why?
| | Foramen Magnum | 2 | 2021 | 10 | 0.270 |
Why?
| | Cerebrovascular Circulation | 5 | 2022 | 289 | 0.270 |
Why?
| | Contrast Media | 4 | 2020 | 500 | 0.260 |
Why?
| | Cerebral Revascularization | 2 | 2020 | 22 | 0.260 |
Why?
| | United Kingdom | 2 | 2025 | 339 | 0.250 |
Why?
| | Motivation | 2 | 2022 | 602 | 0.250 |
Why?
| | Young Adult | 18 | 2025 | 14192 | 0.240 |
Why?
| | Licensure | 1 | 2026 | 16 | 0.240 |
Why?
| | Child | 26 | 2023 | 22680 | 0.240 |
Why?
| | Prospective Studies | 11 | 2025 | 8039 | 0.240 |
Why?
| | Speech Perception | 2 | 2025 | 92 | 0.230 |
Why?
| | Antineoplastic Agents, Alkylating | 2 | 2018 | 72 | 0.230 |
Why?
| | Risk Factors | 10 | 2023 | 10874 | 0.230 |
Why?
| | Washington | 1 | 2026 | 149 | 0.230 |
Why?
| | Sclerosing Solutions | 3 | 2022 | 10 | 0.230 |
Why?
| | Cohort Studies | 11 | 2023 | 5992 | 0.230 |
Why?
| | Healthy Lifestyle | 1 | 2025 | 37 | 0.230 |
Why?
| | Iatrogenic Disease | 1 | 2026 | 74 | 0.230 |
Why?
| | Mutation | 6 | 2021 | 4093 | 0.220 |
Why?
| | Embolectomy | 2 | 2017 | 13 | 0.220 |
Why?
| | Preoperative Care | 3 | 2021 | 380 | 0.220 |
Why?
| | Meningioma | 2 | 2016 | 88 | 0.220 |
Why?
| | Catheterization | 2 | 2017 | 185 | 0.220 |
Why?
| | Drainage | 1 | 2026 | 185 | 0.220 |
Why?
| | Time Factors | 4 | 2025 | 7171 | 0.220 |
Why?
| | Cervical Vertebrae | 2 | 2025 | 167 | 0.220 |
Why?
| | Equipment Design | 6 | 2025 | 532 | 0.220 |
Why?
| | Intracranial Arteriosclerosis | 2 | 2014 | 8 | 0.210 |
Why?
| | Perfusion Imaging | 3 | 2022 | 65 | 0.210 |
Why?
| | Infant | 13 | 2023 | 10064 | 0.210 |
Why?
| | Mosaicism | 2 | 2021 | 73 | 0.200 |
Why?
| | Radiography | 4 | 2014 | 852 | 0.200 |
Why?
| | Microsurgery | 2 | 2021 | 75 | 0.200 |
Why?
| | Transverse Sinuses | 1 | 2023 | 9 | 0.200 |
Why?
| | Imaging, Three-Dimensional | 3 | 2020 | 587 | 0.200 |
Why?
| | Evoked Potentials, Motor | 2 | 2020 | 52 | 0.200 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 3 | 2011 | 105 | 0.200 |
Why?
| | Computed Tomography Angiography | 3 | 2020 | 146 | 0.190 |
Why?
| | Swine | 6 | 2018 | 833 | 0.190 |
Why?
| | Implosive Therapy | 1 | 2023 | 48 | 0.190 |
Why?
| | Cerebral Cortex | 3 | 2022 | 471 | 0.180 |
Why?
| | Neurosurgical Procedures | 5 | 2022 | 203 | 0.180 |
Why?
| | Radiology, Interventional | 1 | 2023 | 49 | 0.180 |
Why?
| | Flow Cytometry | 2 | 2017 | 1156 | 0.180 |
Why?
| | Cochlear Implantation | 2 | 2025 | 83 | 0.180 |
Why?
| | Oxygen | 2 | 2025 | 986 | 0.180 |
Why?
| | Child, Preschool | 15 | 2021 | 11837 | 0.180 |
Why?
| | Giant Cell Arteritis | 1 | 2022 | 48 | 0.170 |
Why?
| | Materials Testing | 2 | 2020 | 348 | 0.170 |
Why?
| | Polyarteritis Nodosa | 1 | 2021 | 11 | 0.170 |
Why?
| | Machine Learning | 2 | 2024 | 590 | 0.170 |
Why?
| | Actins | 2 | 2013 | 421 | 0.170 |
Why?
| | Hematoma | 1 | 2021 | 63 | 0.170 |
Why?
| | Combined Modality Therapy | 3 | 2016 | 1269 | 0.170 |
Why?
| | Methamphetamine | 1 | 2022 | 74 | 0.170 |
Why?
| | Gene Expression | 2 | 2017 | 1478 | 0.170 |
Why?
| | Program Evaluation | 1 | 2025 | 945 | 0.170 |
Why?
| | Angioplasty, Balloon | 1 | 2022 | 101 | 0.170 |
Why?
| | Iodine Compounds | 1 | 2020 | 4 | 0.170 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2021 | 31 | 0.170 |
Why?
| | Moyamoya Disease | 1 | 2020 | 20 | 0.160 |
Why?
| | Surgery, Computer-Assisted | 2 | 2019 | 84 | 0.160 |
Why?
| | Brain Infarction | 1 | 2020 | 23 | 0.160 |
Why?
| | Precision Medicine | 1 | 2025 | 456 | 0.160 |
Why?
| | Blood Vessels | 1 | 2022 | 167 | 0.160 |
Why?
| | Phenotype | 5 | 2021 | 3157 | 0.160 |
Why?
| | Growth Disorders | 1 | 2021 | 88 | 0.160 |
Why?
| | Orbit | 2 | 2011 | 66 | 0.160 |
Why?
| | Spinal Cord Diseases | 1 | 2020 | 42 | 0.160 |
Why?
| | Observer Variation | 2 | 2020 | 358 | 0.160 |
Why?
| | Telangiectasia, Hereditary Hemorrhagic | 1 | 2020 | 14 | 0.160 |
Why?
| | Nervous System Diseases | 2 | 2021 | 287 | 0.160 |
Why?
| | Recurrence | 3 | 2020 | 1142 | 0.160 |
Why?
| | Multivariate Analysis | 3 | 2020 | 1544 | 0.160 |
Why?
| | Calcium Channel Blockers | 2 | 2022 | 166 | 0.160 |
Why?
| | Head Injuries, Penetrating | 1 | 2020 | 6 | 0.160 |
Why?
| | Models, Anatomic | 1 | 2020 | 89 | 0.160 |
Why?
| | Unconsciousness | 1 | 2020 | 23 | 0.150 |
Why?
| | Drug Administration Schedule | 1 | 2022 | 782 | 0.150 |
Why?
| | Equipment Failure Analysis | 2 | 2025 | 124 | 0.150 |
Why?
| | Pyrimidinones | 1 | 2020 | 125 | 0.150 |
Why?
| | Printing, Three-Dimensional | 1 | 2020 | 101 | 0.150 |
Why?
| | Torticollis | 1 | 2019 | 17 | 0.150 |
Why?
| | Amnesia | 1 | 2019 | 47 | 0.150 |
Why?
| | Brain Stem | 1 | 2020 | 98 | 0.150 |
Why?
| | Polyvinyls | 2 | 2016 | 20 | 0.150 |
Why?
| | Reproducibility of Results | 7 | 2020 | 3424 | 0.150 |
Why?
| | Mental Health | 2 | 2024 | 795 | 0.150 |
Why?
| | Behavioral Symptoms | 1 | 2019 | 41 | 0.150 |
Why?
| | Follow-Up Studies | 9 | 2021 | 5426 | 0.150 |
Why?
| | Dimethyl Sulfoxide | 2 | 2016 | 42 | 0.150 |
Why?
| | DCC Receptor | 1 | 2019 | 5 | 0.150 |
Why?
| | Mental Health Services | 1 | 2024 | 472 | 0.140 |
Why?
| | Blood Flow Velocity | 2 | 2017 | 420 | 0.140 |
Why?
| | Models, Neurological | 1 | 2021 | 250 | 0.140 |
Why?
| | Electrocardiography | 3 | 1998 | 669 | 0.140 |
Why?
| | Blood Pressure | 1 | 2025 | 1782 | 0.140 |
Why?
| | Aspirin | 1 | 2022 | 407 | 0.140 |
Why?
| | Rabbits | 2 | 2022 | 651 | 0.140 |
Why?
| | Pyridones | 1 | 2020 | 208 | 0.140 |
Why?
| | Postoperative Hemorrhage | 1 | 2019 | 106 | 0.140 |
Why?
| | Family Health | 1 | 2019 | 191 | 0.140 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2019 | 550 | 0.140 |
Why?
| | Movement Disorders | 1 | 2019 | 70 | 0.140 |
Why?
| | Cell Count | 1 | 2019 | 320 | 0.140 |
Why?
| | Vascular Patency | 1 | 2018 | 130 | 0.140 |
Why?
| | Plaque, Atherosclerotic | 1 | 2019 | 61 | 0.140 |
Why?
| | Migraine Disorders | 1 | 2020 | 115 | 0.140 |
Why?
| | Retinal Vein | 1 | 2018 | 14 | 0.140 |
Why?
| | Blood-Brain Barrier | 1 | 2019 | 157 | 0.130 |
Why?
| | Vascular Diseases | 1 | 2021 | 252 | 0.130 |
Why?
| | Heterozygote | 1 | 2019 | 313 | 0.130 |
Why?
| | Receptor, TIE-1 | 1 | 2017 | 1 | 0.130 |
Why?
| | Diagnosis, Differential | 3 | 2017 | 1507 | 0.130 |
Why?
| | Endoglin | 1 | 2017 | 19 | 0.130 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2017 | 55 | 0.130 |
Why?
| | Biomarkers | 2 | 2026 | 4283 | 0.130 |
Why?
| | Gyrus Cinguli | 1 | 2017 | 96 | 0.130 |
Why?
| | Phlebography | 1 | 2017 | 41 | 0.130 |
Why?
| | Prognosis | 9 | 2023 | 4323 | 0.130 |
Why?
| | von Willebrand Factor | 1 | 2017 | 85 | 0.130 |
Why?
| | Predictive Value of Tests | 6 | 2026 | 2129 | 0.130 |
Why?
| | Stress, Psychological | 1 | 2025 | 1153 | 0.130 |
Why?
| | Diagnostic Errors | 1 | 2018 | 179 | 0.130 |
Why?
| | Radiographic Image Enhancement | 1 | 2017 | 57 | 0.130 |
Why?
| | Memory | 1 | 2019 | 297 | 0.120 |
Why?
| | Retinal Diseases | 1 | 2018 | 101 | 0.120 |
Why?
| | Infant, Newborn | 8 | 2023 | 6437 | 0.120 |
Why?
| | Carotid Arteries | 1 | 2017 | 208 | 0.120 |
Why?
| | Microvessels | 1 | 2017 | 98 | 0.120 |
Why?
| | Workflow | 1 | 2017 | 184 | 0.120 |
Why?
| | Depressive Disorder | 1 | 2019 | 387 | 0.120 |
Why?
| | Depression | 3 | 2022 | 1573 | 0.120 |
Why?
| | Health Care Costs | 1 | 2019 | 427 | 0.120 |
Why?
| | Tantalum | 1 | 2015 | 3 | 0.120 |
Why?
| | Meningeal Arteries | 1 | 2015 | 3 | 0.120 |
Why?
| | Thalamus | 1 | 2017 | 127 | 0.120 |
Why?
| | Ferrous Compounds | 1 | 2015 | 26 | 0.120 |
Why?
| | Renal Artery | 1 | 2016 | 43 | 0.120 |
Why?
| | Magnets | 1 | 2015 | 21 | 0.120 |
Why?
| | Hematoma, Subdural, Intracranial | 1 | 2015 | 2 | 0.120 |
Why?
| | Cardiac Surgical Procedures | 1 | 2022 | 613 | 0.110 |
Why?
| | Quality Improvement | 1 | 2024 | 1294 | 0.110 |
Why?
| | Meningeal Neoplasms | 1 | 2016 | 95 | 0.110 |
Why?
| | American Heart Association | 1 | 2017 | 360 | 0.110 |
Why?
| | Ferric Compounds | 1 | 2015 | 54 | 0.110 |
Why?
| | Aneurysm, False | 1 | 2015 | 46 | 0.110 |
Why?
| | Filtration | 1 | 2015 | 71 | 0.110 |
Why?
| | Antineoplastic Agents | 2 | 2018 | 2207 | 0.110 |
Why?
| | Gene Expression Profiling | 2 | 2022 | 1769 | 0.110 |
Why?
| | Genotype | 1 | 2020 | 1853 | 0.110 |
Why?
| | Blood Glucose | 1 | 2025 | 2330 | 0.110 |
Why?
| | Time-to-Treatment | 1 | 2017 | 250 | 0.110 |
Why?
| | Hemodynamics | 2 | 2017 | 1116 | 0.110 |
Why?
| | Hearing Loss | 1 | 2019 | 249 | 0.110 |
Why?
| | Telemedicine | 1 | 2024 | 960 | 0.110 |
Why?
| | Collateral Circulation | 1 | 2015 | 19 | 0.110 |
Why?
| | Laser Capture Microdissection | 1 | 2014 | 29 | 0.110 |
Why?
| | Biopsy, Needle | 1 | 2015 | 185 | 0.110 |
Why?
| | Intracranial Hypertension | 1 | 2015 | 42 | 0.110 |
Why?
| | Lasers | 1 | 2015 | 128 | 0.110 |
Why?
| | Primary Health Care | 1 | 2025 | 1734 | 0.110 |
Why?
| | Drug Carriers | 1 | 2015 | 134 | 0.110 |
Why?
| | Radiotherapy Planning, Computer-Assisted | 1 | 2015 | 149 | 0.110 |
Why?
| | Myocardial Infarction | 3 | 1998 | 1216 | 0.110 |
Why?
| | Vein of Galen Malformations | 1 | 2014 | 2 | 0.110 |
Why?
| | DNA, Complementary | 1 | 2014 | 273 | 0.100 |
Why?
| | Prefrontal Cortex | 1 | 2017 | 334 | 0.100 |
Why?
| | Magnetic Phenomena | 1 | 2014 | 11 | 0.100 |
Why?
| | Decision Making | 2 | 2021 | 979 | 0.100 |
Why?
| | Protein Kinase Inhibitors | 1 | 2020 | 980 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 339 | 0.100 |
Why?
| | Severity of Illness Index | 1 | 2022 | 2945 | 0.100 |
Why?
| | Reference Values | 1 | 2015 | 797 | 0.100 |
Why?
| | Cerebral Arterial Diseases | 1 | 2013 | 50 | 0.100 |
Why?
| | Optical Imaging | 1 | 2014 | 61 | 0.100 |
Why?
| | Recovery of Function | 1 | 2018 | 716 | 0.100 |
Why?
| | Tungsten | 1 | 2013 | 30 | 0.100 |
Why?
| | Artifacts | 1 | 2014 | 143 | 0.100 |
Why?
| | Alloys | 1 | 2013 | 38 | 0.100 |
Why?
| | Skin | 2 | 2017 | 766 | 0.100 |
Why?
| | Intracranial Thrombosis | 1 | 2012 | 19 | 0.090 |
Why?
| | Neck | 2 | 2023 | 108 | 0.090 |
Why?
| | Ketones | 1 | 2013 | 53 | 0.090 |
Why?
| | Costs and Cost Analysis | 2 | 2026 | 221 | 0.090 |
Why?
| | Carboxypeptidases | 1 | 1992 | 12 | 0.090 |
Why?
| | Paresis | 1 | 2012 | 30 | 0.090 |
Why?
| | Comorbidity | 2 | 2014 | 1659 | 0.090 |
Why?
| | Radiation Dosage | 1 | 2014 | 196 | 0.090 |
Why?
| | Aorta, Abdominal | 1 | 2012 | 52 | 0.090 |
Why?
| | Animals | 9 | 2022 | 38141 | 0.090 |
Why?
| | Zygoma | 1 | 2011 | 7 | 0.090 |
Why?
| | Proteoglycans | 1 | 1992 | 112 | 0.090 |
Why?
| | Cranial Sinuses | 2 | 2021 | 16 | 0.090 |
Why?
| | Cells, Cultured | 2 | 2022 | 4127 | 0.090 |
Why?
| | Serine Endopeptidases | 1 | 1992 | 129 | 0.080 |
Why?
| | Peptide Hydrolases | 1 | 1992 | 106 | 0.080 |
Why?
| | Ethanol | 1 | 2015 | 632 | 0.080 |
Why?
| | RNA, Messenger | 1 | 2019 | 2820 | 0.080 |
Why?
| | Mast Cells | 1 | 1992 | 148 | 0.080 |
Why?
| | Health Personnel | 1 | 2017 | 750 | 0.080 |
Why?
| | Patient Admission | 1 | 2012 | 221 | 0.080 |
Why?
| | Cell Survival | 1 | 2013 | 1094 | 0.080 |
Why?
| | Parents | 1 | 2019 | 1404 | 0.080 |
Why?
| | Cerebral Ventriculography | 1 | 2010 | 2 | 0.080 |
Why?
| | Angiography | 3 | 2018 | 211 | 0.080 |
Why?
| | Echoencephalography | 1 | 2010 | 4 | 0.080 |
Why?
| | Hot Temperature | 1 | 2013 | 411 | 0.080 |
Why?
| | Organotechnetium Compounds | 1 | 2010 | 12 | 0.080 |
Why?
| | Cerebral Ventricles | 1 | 2010 | 55 | 0.080 |
Why?
| | Fibroblasts | 3 | 2026 | 1023 | 0.080 |
Why?
| | Spinal Neoplasms | 1 | 2009 | 37 | 0.080 |
Why?
| | Anxiety Disorders | 2 | 2023 | 370 | 0.070 |
Why?
| | Datasets as Topic | 2 | 2020 | 119 | 0.070 |
Why?
| | Psychiatric Status Rating Scales | 2 | 2024 | 539 | 0.070 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2022 | 444 | 0.070 |
Why?
| | Quality of Life | 1 | 2022 | 3195 | 0.070 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 2594 | 0.070 |
Why?
| | Hydrocephalus | 1 | 2010 | 111 | 0.070 |
Why?
| | Functional Laterality | 2 | 2020 | 242 | 0.070 |
Why?
| | Emergency Medical Services | 1 | 1996 | 697 | 0.070 |
Why?
| | Sensitivity and Specificity | 4 | 2020 | 2002 | 0.070 |
Why?
| | Cysteine | 1 | 2010 | 208 | 0.070 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2019 | 780 | 0.070 |
Why?
| | Rupture | 2 | 2020 | 91 | 0.070 |
Why?
| | Arteries | 2 | 2022 | 261 | 0.070 |
Why?
| | Polyethylene Glycols | 1 | 2013 | 652 | 0.070 |
Why?
| | RNA | 1 | 2014 | 929 | 0.070 |
Why?
| | Constriction, Pathologic | 2 | 2022 | 252 | 0.070 |
Why?
| | ROC Curve | 2 | 2022 | 619 | 0.070 |
Why?
| | Brain Injuries | 1 | 2013 | 507 | 0.070 |
Why?
| | Electromyography | 2 | 2020 | 419 | 0.060 |
Why?
| | Cerebellum | 2 | 2019 | 224 | 0.060 |
Why?
| | Case-Control Studies | 3 | 2019 | 3619 | 0.060 |
Why?
| | Longitudinal Studies | 3 | 2025 | 2950 | 0.060 |
Why?
| | Electronic Health Records | 2 | 2024 | 1187 | 0.060 |
Why?
| | Injections, Intra-Arterial | 2 | 2015 | 26 | 0.060 |
Why?
| | Registries | 1 | 2015 | 2410 | 0.060 |
Why?
| | Atlases as Topic | 1 | 2025 | 11 | 0.060 |
Why?
| | Reperfusion | 1 | 2025 | 54 | 0.060 |
Why?
| | Disease Models, Animal | 2 | 2015 | 4559 | 0.060 |
Why?
| | Anxiety | 2 | 2023 | 1127 | 0.050 |
Why?
| | Music | 1 | 2025 | 48 | 0.050 |
Why?
| | Regional Blood Flow | 2 | 2018 | 515 | 0.050 |
Why?
| | Patient Health Questionnaire | 1 | 2024 | 40 | 0.050 |
Why?
| | Age Distribution | 2 | 2014 | 403 | 0.050 |
Why?
| | Surveys and Questionnaires | 3 | 2022 | 6070 | 0.050 |
Why?
| | Camping | 1 | 2023 | 3 | 0.050 |
Why?
| | Fibrosis | 1 | 2026 | 551 | 0.050 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2020 | 3917 | 0.050 |
Why?
| | Phobic Disorders | 1 | 2023 | 35 | 0.050 |
Why?
| | Hypertension | 1 | 2012 | 1273 | 0.050 |
Why?
| | Models, Animal | 2 | 2016 | 395 | 0.050 |
Why?
| | Cost-Benefit Analysis | 1 | 2026 | 645 | 0.050 |
Why?
| | Physician's Role | 1 | 2024 | 222 | 0.050 |
Why?
| | Glasgow Coma Scale | 1 | 2023 | 218 | 0.050 |
Why?
| | Doxycycline | 1 | 2022 | 62 | 0.050 |
Why?
| | Technology | 1 | 2022 | 95 | 0.040 |
Why?
| | Cross-Sectional Studies | 3 | 2022 | 5891 | 0.040 |
Why?
| | Psychiatry | 1 | 2024 | 196 | 0.040 |
Why?
| | Pericytes | 1 | 2022 | 37 | 0.040 |
Why?
| | Age Factors | 2 | 2021 | 3340 | 0.040 |
Why?
| | Head | 1 | 2022 | 121 | 0.040 |
Why?
| | Sodium | 1 | 2022 | 198 | 0.040 |
Why?
| | Skin Abnormalities | 1 | 2021 | 12 | 0.040 |
Why?
| | Mood Disorders | 1 | 2022 | 140 | 0.040 |
Why?
| | Aging, Premature | 1 | 2021 | 16 | 0.040 |
Why?
| | Intraoperative Period | 1 | 2021 | 69 | 0.040 |
Why?
| | Psychosocial Support Systems | 1 | 2020 | 16 | 0.040 |
Why?
| | Expert Testimony | 1 | 2020 | 42 | 0.040 |
Why?
| | Delayed Diagnosis | 1 | 2021 | 100 | 0.040 |
Why?
| | Intention | 1 | 2022 | 187 | 0.040 |
Why?
| | Models, Theoretical | 2 | 2014 | 579 | 0.040 |
Why?
| | Vietnam Conflict | 1 | 2020 | 5 | 0.040 |
Why?
| | Patient Advocacy | 1 | 2020 | 73 | 0.040 |
Why?
| | Survival Rate | 2 | 2014 | 2093 | 0.040 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2021 | 189 | 0.040 |
Why?
| | Headache | 1 | 2021 | 151 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2021 | 176 | 0.040 |
Why?
| | Coma | 1 | 2020 | 38 | 0.040 |
Why?
| | Canada | 1 | 2021 | 434 | 0.040 |
Why?
| | Behavior Observation Techniques | 1 | 2019 | 10 | 0.040 |
Why?
| | Defense Mechanisms | 1 | 2019 | 21 | 0.040 |
Why?
| | Syndrome | 1 | 2020 | 380 | 0.040 |
Why?
| | Age of Onset | 1 | 2021 | 554 | 0.040 |
Why?
| | Corneal Edema | 1 | 1999 | 4 | 0.040 |
Why?
| | Neural Inhibition | 1 | 2020 | 178 | 0.040 |
Why?
| | Carbonic Anhydrase Inhibitors | 1 | 1999 | 14 | 0.040 |
Why?
| | Endothelium, Corneal | 1 | 1999 | 18 | 0.040 |
Why?
| | Monocytes | 1 | 2022 | 536 | 0.040 |
Why?
| | Visual Cortex | 1 | 2020 | 84 | 0.040 |
Why?
| | Diplopia | 1 | 2019 | 28 | 0.040 |
Why?
| | Gray Matter | 1 | 2020 | 92 | 0.040 |
Why?
| | Basal Ganglia | 1 | 2019 | 57 | 0.040 |
Why?
| | Refractive Errors | 1 | 1999 | 36 | 0.040 |
Why?
| | Propensity Score | 1 | 2021 | 376 | 0.040 |
Why?
| | Pyramidal Tracts | 1 | 2019 | 30 | 0.040 |
Why?
| | Functional Neuroimaging | 1 | 2019 | 60 | 0.040 |
Why?
| | Cranial Nerve Diseases | 1 | 2019 | 44 | 0.040 |
Why?
| | Carotid Artery Diseases | 1 | 2019 | 70 | 0.040 |
Why?
| | Corpus Callosum | 1 | 2019 | 72 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2022 | 359 | 0.030 |
Why?
| | Motor Cortex | 1 | 2019 | 66 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2020 | 517 | 0.030 |
Why?
| | Thiophenes | 1 | 1999 | 121 | 0.030 |
Why?
| | Social Behavior | 1 | 2020 | 288 | 0.030 |
Why?
| | Symptom Assessment | 1 | 2019 | 136 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2021 | 1049 | 0.030 |
Why?
| | Polytetrafluoroethylene | 1 | 1998 | 24 | 0.030 |
Why?
| | Dermatologic Surgical Procedures | 1 | 1998 | 23 | 0.030 |
Why?
| | Paracentesis | 1 | 2018 | 16 | 0.030 |
Why?
| | Problem Behavior | 1 | 2019 | 101 | 0.030 |
Why?
| | Groin | 1 | 2017 | 13 | 0.030 |
Why?
| | Anterior Cerebral Artery | 1 | 2017 | 5 | 0.030 |
Why?
| | Coronary Disease | 1 | 2000 | 381 | 0.030 |
Why?
| | Coronary Care Units | 1 | 1998 | 27 | 0.030 |
Why?
| | Punctures | 1 | 2017 | 41 | 0.030 |
Why?
| | Injections, Intravenous | 1 | 2018 | 199 | 0.030 |
Why?
| | Middle Cerebral Artery | 1 | 2017 | 56 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2021 | 553 | 0.030 |
Why?
| | Analysis of Variance | 2 | 2000 | 1304 | 0.030 |
Why?
| | Echocardiography | 1 | 2000 | 648 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 366 | 0.030 |
Why?
| | Carotid Artery, External | 1 | 2016 | 3 | 0.030 |
Why?
| | Ventricular Function, Left | 1 | 2000 | 539 | 0.030 |
Why?
| | Drug Delivery Systems | 1 | 2020 | 382 | 0.030 |
Why?
| | Prostheses and Implants | 1 | 1998 | 142 | 0.030 |
Why?
| | Postoperative Complications | 2 | 2021 | 2962 | 0.030 |
Why?
| | Hemorrhage | 1 | 2022 | 826 | 0.030 |
Why?
| | Movement | 1 | 2019 | 296 | 0.030 |
Why?
| | Blood Volume | 1 | 2016 | 65 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2020 | 2137 | 0.030 |
Why?
| | Parent-Child Relations | 1 | 2019 | 271 | 0.030 |
Why?
| | Immunosuppressive Agents | 1 | 2021 | 842 | 0.030 |
Why?
| | Smoking | 1 | 2023 | 1468 | 0.030 |
Why?
| | Gray Platelet Syndrome | 1 | 2015 | 4 | 0.030 |
Why?
| | Genetic Variation | 1 | 2021 | 988 | 0.030 |
Why?
| | Fibrous Dysplasia, Polyostotic | 1 | 2015 | 6 | 0.030 |
Why?
| | United States | 3 | 2021 | 16115 | 0.030 |
Why?
| | Venous Pressure | 1 | 2015 | 6 | 0.030 |
Why?
| | Dexamethasone | 1 | 2018 | 366 | 0.030 |
Why?
| | Image Enhancement | 1 | 2016 | 200 | 0.030 |
Why?
| | Mental Disorders | 1 | 2024 | 1157 | 0.030 |
Why?
| | Confidence Intervals | 1 | 1996 | 331 | 0.030 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2016 | 427 | 0.030 |
Why?
| | Drug Compounding | 1 | 2015 | 107 | 0.030 |
Why?
| | Sex Distribution | 1 | 1996 | 387 | 0.030 |
Why?
| | Diffusion | 1 | 2015 | 124 | 0.030 |
Why?
| | Sulfonamides | 1 | 1999 | 581 | 0.030 |
Why?
| | Health Behavior | 1 | 2020 | 788 | 0.030 |
Why?
| | Models, Cardiovascular | 1 | 2015 | 197 | 0.030 |
Why?
| | DNA | 1 | 2021 | 1451 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2015 | 284 | 0.030 |
Why?
| | Particle Size | 1 | 2015 | 402 | 0.030 |
Why?
| | Prevalence | 1 | 2021 | 2855 | 0.030 |
Why?
| | Mydriasis | 1 | 2013 | 10 | 0.030 |
Why?
| | Multimodal Imaging | 1 | 2015 | 129 | 0.030 |
Why?
| | Perfusion | 1 | 2015 | 249 | 0.030 |
Why?
| | Biocompatible Materials | 1 | 1998 | 436 | 0.030 |
Why?
| | Electromagnetic Radiation | 1 | 2013 | 3 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2018 | 1058 | 0.020 |
Why?
| | Causality | 1 | 2014 | 127 | 0.020 |
Why?
| | Pandemics | 1 | 2022 | 1706 | 0.020 |
Why?
| | Glucocorticoids | 1 | 2018 | 531 | 0.020 |
Why?
| | Benzophenones | 1 | 2013 | 15 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2014 | 335 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2013 | 303 | 0.020 |
Why?
| | Alzheimer Disease | 1 | 2019 | 631 | 0.020 |
Why?
| | Chymases | 1 | 1992 | 8 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 2355 | 0.020 |
Why?
| | California | 1 | 2014 | 483 | 0.020 |
Why?
| | Breast Neoplasms | 1 | 2025 | 2373 | 0.020 |
Why?
| | Chromatography, Affinity | 1 | 1992 | 80 | 0.020 |
Why?
| | Chromatography, Gel | 1 | 1992 | 128 | 0.020 |
Why?
| | Molecular Weight | 1 | 1992 | 312 | 0.020 |
Why?
| | Exocytosis | 1 | 1992 | 85 | 0.020 |
Why?
| | Inflammation | 1 | 2022 | 2883 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2020 | 1794 | 0.020 |
Why?
| | Pilot Projects | 1 | 2016 | 1896 | 0.020 |
Why?
| | Pregnancy | 1 | 2022 | 7197 | 0.020 |
Why?
| | Polymers | 1 | 2013 | 494 | 0.020 |
Why?
| | Blood Loss, Surgical | 1 | 2009 | 112 | 0.020 |
Why?
| | Signal Transduction | 1 | 2021 | 5202 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2862 | 0.020 |
Why?
| | Veterans | 1 | 2020 | 1626 | 0.020 |
Why?
| | Carcinoma, Renal Cell | 1 | 2009 | 234 | 0.020 |
Why?
| | Incidence | 1 | 2014 | 2915 | 0.020 |
Why?
| | Databases, Factual | 1 | 2012 | 1500 | 0.010 |
Why?
| | Kidney Neoplasms | 1 | 2009 | 416 | 0.010 |
Why?
| | Technetium Tc 99m Sestamibi | 1 | 2000 | 13 | 0.010 |
Why?
| | Radiopharmaceuticals | 1 | 2000 | 207 | 0.010 |
Why?
| | Keratoplasty, Penetrating | 1 | 1999 | 9 | 0.010 |
Why?
| | Administration, Topical | 1 | 1999 | 153 | 0.010 |
Why?
| | Ophthalmic Solutions | 1 | 1999 | 80 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1998 | 164 | 0.010 |
Why?
| | Swine, Miniature | 1 | 1998 | 89 | 0.010 |
Why?
| | Regression Analysis | 1 | 2000 | 1001 | 0.010 |
Why?
| | Equipment Failure | 1 | 1998 | 116 | 0.010 |
Why?
| | Electrodes | 1 | 1998 | 112 | 0.010 |
Why?
| | Angioplasty, Balloon, Coronary | 1 | 1998 | 158 | 0.010 |
Why?
| | Surface Properties | 1 | 1998 | 398 | 0.010 |
Why?
| | Intraocular Pressure | 1 | 1999 | 326 | 0.010 |
Why?
| | Lymphocytes | 1 | 1998 | 379 | 0.010 |
Why?
| | Visual Acuity | 1 | 1999 | 491 | 0.010 |
Why?
| | Glaucoma | 1 | 1999 | 247 | 0.010 |
Why?
| | Fibrinolytic Agents | 1 | 1998 | 297 | 0.010 |
Why?
| | Surgical Wound Infection | 1 | 1998 | 330 | 0.010 |
Why?
| | Heart Ventricles | 1 | 1998 | 754 | 0.010 |
Why?
| | Neutrophils | 1 | 1998 | 1124 | 0.010 |
Why?
|
|
Cooke's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|